Evaluation and management of left ventricular noncompaction cardiomyopathy

R Brandon Stacey1, Augustus J Caine, W Gregory Hundley

  • 1Department of Internal Medicine Section on Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA, bstacey@wakehealth.edu.

Insights

Left ventricular noncompaction cardiomyopathy (LVNC) involves underdeveloped heart muscle. Improved imaging aids diagnosis, but distinguishing it from minor trabeculations requires careful evaluation and clinical correlation.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Medical Imaging

Background:

  • Left ventricular (LV) noncompaction cardiomyopathy (LVNC) is a congenital heart muscle disorder.
  • It results from impaired compaction of the fetal endocardium during development.
  • LVNC is linked to reduced LV function, high mortality, arrhythmias, and embolism.

Purpose of the Study:

  • To review methods for evaluating LV trabeculations.
  • To discuss the significance of increased trabeculations in cardiovascular disease.
  • To explore the impact of trabeculations on clinical management.

Main Methods:

  • Review of current medical literature and imaging techniques.
  • Analysis of diagnostic criteria for LVNC.
  • Correlation of imaging findings with clinical outcomes.

Main Results:

  • Improved imaging quality enhances identification of LV trabeculations.
  • Distinguishing true LVNC from increased trabeculations necessitates expert interpretation.
  • Trabeculation patterns offer insights into cardiac function and disease progression.

Conclusions:

  • Accurate diagnosis of LVNC relies on advanced imaging and clinical correlation.
  • Understanding trabeculation patterns is crucial for risk stratification and management.
  • Further research can refine diagnostic and therapeutic strategies for LVNC.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
814
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
732
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
943
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
473
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K